Christopher J. Parkinson

2.8k citations

58 papers · 2.3k indexed · 1 hit paper · h-index 20

Organic Chemistry top 2%
Molecular Biology
Public Health, Environmental and Occupational Health top 5%
Atomic and Molecular Physics, and Optics top 10%
Epidemiology top 10%

Co-authors: Leo Radom P. Mayer S Millott Richard Palmer Foo Y. Liew Salvador Moncada David J. Henry Charles B. de Koning
Topics: Asymmetric Synthesis and Catalysis (7 papers)Tuberculosis Research and Epidemiology (5 papers)Computational Drug Discovery Methods (5 papers)
Cited by: Organic Chemistry Physical and Theoretical Chemistry Parasitology
Journals: The Journal of Chemical Physics The Journal of Immunology PLoS ONE
Partner nations: Australia South Africa United Kingdom

In The Last Decade

Christopher J. Parkinson

56 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from l -arginine.

1990 631 citations Foo Y. Liew, S Millott et al. The Journal of Immunology profile →

Peers

Countries citing papers authored by Christopher J. Parkinson

Since Specialization

Citations

This map shows the geographic impact of Christopher J. Parkinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Parkinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Parkinson more than expected).

Fields of papers citing papers by Christopher J. Parkinson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Parkinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Parkinson. The network helps show where Christopher J. Parkinson may publish in the future.

Co-authorship network of co-authors of Christopher J. Parkinson

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher J. Parkinson. A scholar is included among the top collaborators of Christopher J. Parkinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher J. Parkinson. Christopher J. Parkinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacies and ADME properties of redox active methylene blue and phenoxazine analogues for use in new antimalarial triple drug combinations with amino-artemisinins 2024 ·Frontiers in Pharmacology ·Daniel J. Watson,(unknown),Jacobus P. Petzer,Ho Ning Wong,Christopher J. Parkinson,Lubbe Wiesner,Richard K. Haynes	0
2	In Vitro Efficacies, ADME, and Pharmacokinetic Properties of Phenoxazine Derivatives Active against Mycobacterium tuberculosis 2019 ·Antimicrobial Agents and Chemotherapy ·Lloyd Tanner,Joanna C. Evans,Ronnett Seldon,Audrey Jordaan,Digby F. Warner,Richard K. Haynes,Christopher J. Parkinson,Lubbe Wiesner	25
3	Differential inhibition of adenylylated and deadenylylated forms of M. tuberculosis glutamine synthetase as a drug discovery platform 2017 ·PLoS ONE ·Anjo Theron,(unknown),H. H. Hoppe,Christopher J. Parkinson,Christiaan W. van der Westhuyzen,Stoyan Stoychev,Ian Wiid,(unknown),Bienyameen Baker,Colin Kenyon	14
4	Cytotoxic activity of expanded coordination bis-thiosemicarbazones and copper complexes thereof 2016 ·JBIC Journal of Biological Inorganic Chemistry ·(unknown),Scott D. Andrew,Christopher J. Parkinson	21
5	Increased generation of intracellular reactive oxygen species initiates selective cytotoxicity against the MCF-7 cell line resultant from redox active combination therapy using copper–thiosemicarbazone complexes 2016 ·JBIC Journal of Biological Inorganic Chemistry ·(unknown),Scott D. Andrew,Christopher J. Parkinson	12
6	Investigation of the cytotoxic implications of metal chelators against melanoma and approaches to improve the cytotoxicity profiles of metal coordinating agents 2016 ·BioMetals ·(unknown),Scott D. Andrew,Christopher J. Parkinson	4
7	Improved cytotoxicity of pyridyl-substituted thiosemicarbazones against MCF-7 when used as metal ionophores 2015 ·BioMetals ·(unknown),Scott D. Andrew,Christopher J. Parkinson	8
8	Selective induction of oxidative stress in cancer cells via synergistic combinations of agents targeting redox homeostasis 2015 ·Bioorganic & Medicinal Chemistry ·(unknown),Scott D. Andrew,Christopher J. Parkinson	20
9	Structure-Activity Relationship Study of Sesquiterpene Lactones and Their Semi-Synthetic Amino Derivatives as Potential Antitrypanosomal Products 2014 ·Molecules ·Stefanie Zimmermann,Gerda Fouché,Maria De Mieri,Yukiko Yoshimoto,Toyonobu Usuki,(unknown),Christopher J. Parkinson,Christiaan W. van der Westhuyzen,Marcel Kaiser,Matthias Hamburger,Michael A. Adams	33
10	Conserved phosphoryl transfer mechanisms within kinase families and the role of the C8 proton of ATP in the activation of phosphoryl transfer 2012 ·BMC Research Notes ·Colin Kenyon,(unknown),Christiaan W. van der Westhuyzen,Christopher J. Parkinson	16
11	ATP and luciferase assays to determine the rate of drug action in in vitro cultures of Plasmodium falciparum 2012 ·Malaria Journal ·(unknown),(unknown),Christopher J. Parkinson,Heinrich C. Hoppe	14
12	In vitro anti-plasmodial activity of Dicoma anomala subsp. gerrardii (Asteraceae): identification of its main active constituent, structure-activity relationship studies and gene expression profiling 2011 ·Malaria Journal ·J BECKER,(unknown),(unknown),Pamisha Pillay,B.G. Crampton,Edwin M. Mmutlane,Christopher J. Parkinson,Fanie R. van Heerden,Neil R. Crouch,Peter J. Smith,Dalu Mancama,Vinesh Maharaj	39
13	Multicomponent Synthesis of Imidazo[1,2‐a]pyridines Using Catalytic Zinc Chloride. 2007 ·ChemInform ·Amanda L. Rousseau,(unknown),Christopher J. Parkinson	1
14	Cyanovinyl radical: an illustration of the poor performance of unrestricted perturbation theory and density functional theory procedures in calculating radical stabilization energies 1999 ·Theoretical Chemistry Accounts ·Christopher J. Parkinson,P. Mayer,Leo Radom	57
15	The Timing of Preclinical Toxicological Studies: Pharmaceutical Company Approaches to Toxicity Testing in Support of Initial Clinical Investigations 1996 ·Regulatory Toxicology and Pharmacology ·Christopher J. Parkinson,(unknown),(unknown)	2
16	The Value of Information Generated by Long-Term Toxicity Studies in the Dog for the Nonclinical Safety Assessment of Pharmaceutical Compounds 1995 ·Fundamental and Applied Toxicology ·Christopher J. Parkinson	10
17	The Timing of Toxicological Studies to Support Clinical Trials 1994 ·Christopher J. Parkinson,Neil McAuslane,(unknown),Stuart Walker	5
18	Stereocontrolled synthesis of calyculin A: construction of the C(15)–C(25) spiroketal unit 1992 ·Journal of the Chemical Society Chemical Communications ·Anthony G. M. Barrett,Jeremy J. Edmunds,Kiyoshi Horita,Christopher J. Parkinson	14
19	Amplification and over-expression of c-erbB-2 in transitional cell carcinoma of the urinary bladder 1991 ·British Journal of Cancer ·(unknown),(unknown),(unknown),(unknown),(unknown),Christopher J. Parkinson,Margaret A. Knowles	153
20	Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from l -arginine.breakdown → 1990 ·The Journal of Immunology ·Foo Y. Liew,S Millott,Christopher J. Parkinson,Richard Palmer,Salvador Moncada	631

About Christopher J. Parkinson

Christopher J. Parkinson is a scholar working on Organic Chemistry, Pharmacology and Small Animals, having authored 58 papers that have together received 2.3k indexed citations. Recurring topics across this work include Asymmetric Synthesis and Catalysis (7 papers), Tuberculosis Research and Epidemiology (5 papers) and Computational Drug Discovery Methods (5 papers). The work is most often cited by research in Organic Chemistry (977 citations), Physical and Theoretical Chemistry (186 citations) and Parasitology (116 citations). Christopher J. Parkinson has collaborated with scholars based in Australia, South Africa and United Kingdom. Frequent co-authors include Leo Radom, P. Mayer, S Millott, Richard Palmer, Foo Y. Liew, Salvador Moncada, David J. Henry, Charles B. de Koning, Amanda L. Rousseau and David M. Smith. Their work appears in journals such as The Journal of Chemical Physics, The Journal of Immunology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact